Cargando…
Human immunome, bioinformatic analyses using HLA supermotifs and the parasite genome, binding assays, studies of human T cell responses, and immunization of HLA-A*1101 transgenic mice including novel adjuvants provide a foundation for HLA-A03 restricted CD8(+)T cell epitope based, adjuvanted vaccine protective against Toxoplasma gondii
BACKGROUND: Toxoplasmosis causes loss of life, cognitive and motor function, and sight. A vaccine is greatly needed to prevent this disease. The purpose of this study was to use an immmunosense approach to develop a foundation for development of vaccines to protect humans with the HLA-A03 supertype....
Autores principales: | Cong, Hua, Mui, Ernest J, Witola, William H, Sidney, John, Alexander, Jeff, Sette, Alessandro, Maewal, Ajesh, McLeod, Rima |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3009956/ https://www.ncbi.nlm.nih.gov/pubmed/21129215 http://dx.doi.org/10.1186/1745-7580-6-12 |
Ejemplares similares
-
Toxoplasma gondii peptide ligands open the gate of the HLA class I binding groove
por: McMurtrey, Curtis, et al.
Publicado: (2016) -
HLA-E*01:01 + HLA-E*01:01 genotype confers less susceptibility to COVID-19, while HLA-E*01:03 + HLA-E*01:03 genotype is associated with more severe disease
por: Hosseini, Ehteramolsadat, et al.
Publicado: (2023) -
Predicting HLA CD4 Immunogenicity in Human Populations
por: Dhanda, Sandeep Kumar, et al.
Publicado: (2018) -
Generation of functional HLA-DR*1101 tetramers receptive for loading with pathogen or tumour derived synthetic peptides
por: Moro, Monica, et al.
Publicado: (2005) -
Engineering and characterization of a novel Self Assembling Protein for Toxoplasma peptide vaccine in HLA-A*11:01, HLA-A*02:01 and HLA-B*07:02 transgenic mice
por: El Bissati, Kamal, et al.
Publicado: (2020)